Search

everythinglearnresearchcommunity

for

Search:↓

Poplar seed hairs grow from the placenta at the ovary base, with endoreduplication playing a key role in their development, and share similar cellulose synthesis processes with cotton fibers.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

A woman's hair loss was caused by her husband's testosterone gel and a diabetic man's nail disease led to bone infection, both treated successfully.

TRM21 helps control flavonoid production and root hair growth in Arabidopsis thaliana.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Phosphorylation of certain parts of the PIN3 protein is crucial for its role in plant root growth and response to gravity.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

The document concludes that stem cell therapies lack solid proof of effectiveness, except for blood system treatments, and criticizes the ethical issues and commercial exploitation in the field.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Transplant success has improved with better immunosuppressive drugs and donor matching.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

New therapies are being developed that target integrin pathways to treat various diseases.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

New treatments for lupus show promise, but more research is needed, especially for children.